|
RABGAP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
4.48951986697921E-12 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
6.729200E-01 |
| Stage1-vs-Stage3 |
1.118600E-01 |
| Stage1-vs-Stage4 |
9.808200E-04 |
| Stage2-vs-Stage3 |
5.054800E-01 |
| Stage2-vs-Stage4 |
2.027800E-02 |
| Stage3-vs-Stage4 |
5.076400E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.98875999999348E-05 |
| Normal-vs-Asian |
1.97064586870965E-12 |
| Caucasian-vs-AfricanAmerican |
1.961600E-01 |
| Caucasian-vs-Asian |
6.373600E-01 |
| AfricanAmerican-vs-Asian |
3.277400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62458935193399E-12 |
| Male-vs-Female |
7.489000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.64745994624127E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
2.18040000055097E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.779800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.543800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.337600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.049160E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.475900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.596600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.388600E-04 |
| Classical-VS-Follicular |
9.766400E-01 |
| Classical-VS-Other |
5.449200E-01 |
| Classical-VS-Normal |
1.71829217521235E-12 |
| Tall-VS-Follicular |
2.824600E-03 |
| Tall-VS-Other |
1.420550E-01 |
| Tall-VS-Normal |
1.62436730732907E-12 |
| Follicular-VS-Other |
6.088000E-01 |
| Follicular-VS-Normal |
1.80211401357155E-12 |
| Other-VS-Normal |
3.818700E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.11022302462516E-16 |
| Normal-vs-N1 |
1.36557432028894E-14 |
| N0-vs-N1 |
1.174240E-01 |
|
|
